Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, December 8, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Paul Chaplin | |
| 2. | Reason for the notification | ||
| a) | Position/status | President and Chief Executive Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Warrants DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 0.00 | 88,325 | ||
| d) | Aggregated information
| 88,325 DKK 0.00 | |
| e) | Date of the transaction | 2022-12-08 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Henrik Juuel | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief Financial Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Warrants DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 0.00 | 38,162 | ||
| d) | Aggregated information
| 38,162 DKK 0.00 | |
| e) | Date of the transaction | 2022-12-08 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Jean-Christophe May | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Warrants DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 0.00 | 34,263 | ||
| d) | Aggregated information
| 34,263 DKK 0.00 | |
| e) | Date of the transaction | 2022-12-08 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Laurence De Moerlooze | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief Medical Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Warrants DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 0.00 | 32,934 | ||
| d) | Aggregated information
| 32,934 DKK 0.00 | |
| e) | Date of the transaction | 2022-12-08 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Anu Helena Kerns | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President People & Organization of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Warrants DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 0.00 | 22,902 | ||
| d) | Aggregated information
| 22,902 DKK 0.00 | |
| e) | Date of the transaction | 2022-12-08 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Russell Thirsk | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief Operating Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Warrants DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 0.00 | 32,201 | ||
| d) | Aggregated information
| 32,201 DKK 0.00 | |
| e) | Date of the transaction | 2022-12-08 | |
| f) | Place of the transaction | Outside a trading venue | |
About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Government of a non-replicating smallpox vaccine, which has been approved by the FDA, also for the protection against mpox (monkeypox). The vaccine is also approved in Canada and Europe. Our commercial product portfolio furthermore contains market-leading vaccines against rabies and tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccine. For more information visit www.bavarian-nordic.com.
Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600
Company Announcement no. 44 / 2022
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
PANDORA INITIATES A DKK 2.4 BILLION SHARE BUY-BACK, WITH AN INTENTION TO GO UP TO DKK 5.0 BILLION8.2.2023 07:32:00 CET | Press release
The Board of Directors has decided to launch a new share buy-back programme of DKK 2.4 billion with an intention to go up to a total of DKK 5.0 billion during the next 12 months, depending on how the macroeconomic climate develops throughout the year. Pandora has appointed Danske Bank as lead manager on the initial DKK 2.4 billion buy-back programme, which will run from 8 February 2023 until 30 June 2023. Any subsequent share buy-back programmes will be carried out in the period between 3 July 2023 to 2 February 2024, both days inclusive. The share buy-back programme is implemented in accordance with the safe harbour rules in Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation). The programme will be implemented under the following framework: The maximum total consideration for Pandora shares bought back in the period of the programme is DKK 2.4 billion;Under the current authorisation to acquire treasury shares, and thus a
Pandora Annual Report 20228.2.2023 07:31:00 CET | Press release
Please find the Annual Report for 2022 and Sustainability Report for 2022 enclosed. Attachments Pandora Annual Report 2022PAND-2022-12-31-enPandora Sustainability Report 2022
Nykredit Bank Group - Annual Report 20228.2.2023 07:30:00 CET | Press release
To Nasdaq Copenhagen A/S and the press8 February 2023 Nykredit today announces the Annual Reports for 2022 of: Nykredit A/S, CVR no 12 71 92 48 Nykredit Realkredit A/S, CVR no 12 71 92 80 Nykredit Bank A/S, CVR no 10 51 96 08 Totalkredit A/S, CVR no 21 83 22 78 Michael Rasmussen, Group Chief Executive, comments on the Annual Report 2022: - Nykredit reported its best ever financial results today. And this is highly satisfactory. 2022 was yet another busy year with high business and customer growth in Nykredit Bank and Totalkredit. We have also recorded growth in Nykredit Wealth Management, which includes Nykredit Invest and Sparinvest. However, given the macroeconomic outlook, we cannot expect the same high activity level and results next year. - 2022 was characterised in particular by the war in Ukraine and its impacts, which quickly fed through to the global economy and fuelled volatility. In times like these, I am particularly proud that customers, colleagues and Nykredit on the whol
Rovio Entertainment Corp.: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act8.2.2023 07:30:00 CET | Press release
Rovio Entertainment Corporation Stock Exchange Release February 8, 2023 at 8.30 a.m. EET Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act Rovio Entertainment Corporation (the "Company") has received a notification pursuant to Chapter 9, Section 5 of the Securities Markets Act from Invesco Ltd. According to the notification, the holding of Invesco Ltd. in the Company's shares and votes decreased below the 5% threshold on February 6, 2023. Following the transaction, Invesco Ltd. owns 2.97% of the Company’s shares and voting rights. Total positions of Invesco Ltd.: % of shares and voting rights% of shares and voting rights through financial instrumentsTotal of both in %Total number of shares and voting rights of issuerResulting situation on the date on which threshold was crossed or reached2.9702.9782,963,825Position of previous notification5.8905.89 Notified details of the resulting situation on the date on which the threshold was crossed or re
Nykredit Realkredit Group - Annual Report 20228.2.2023 07:30:00 CET | Press release
To Nasdaq Copenhagen A/S and the press8 February 2023 Nykredit today announces the Annual Reports for 2022 of: Nykredit A/S, CVR no 12 71 92 48 Nykredit Realkredit A/S, CVR no 12 71 92 80 Nykredit Bank A/S, CVR no 10 51 96 08 Totalkredit A/S, CVR no 21 83 22 78 Michael Rasmussen, Group Chief Executive, comments on the Annual Report 2022: - Nykredit reported its best ever financial results today. And this is highly satisfactory. 2022 was yet another busy year with high business and customer growth in Nykredit Bank and Totalkredit. We have also recorded growth in Nykredit Wealth Management, which includes Nykredit Invest and Sparinvest. However, given the macroeconomic outlook, we cannot expect the same high activity level and results next year. - 2022 was characterised in particular by the war in Ukraine and its impacts, which quickly fed through to the global economy and fuelled volatility. In times like these, I am particularly proud that customers, colleagues and Nykredit on the whol